Johnson & Johnson Announces Partnership With U.S. government to Accelerate Coronavirus Vaccine Development

Johnson & Johnson (NYSE: JNJ) announced on Tuesday afternoon that subsidiary Janssen Pharmaceutical will be working together with the U.S. government to expedite the development of a coronavirus vaccine. Specifically, the company will be working with the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services.